In PAH, HNRNPA2B1 was shown to be nuclear and to stabilize its targets, while in cancer HNRNPA2B1 is known to be cytoplasmic and to destabilize its targets [49]. This evidence concerns the gene HNRNPA2B1 and pulmonary arterial hypertension.